Haemonetics Corporation (NYSE:HAE) Q4 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Q4 2025 Haemonetics Corporation Earnings Conference Call.
Haemonetics Corp (HAE)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Royce & Associates Chuck Royce | 1,161,296 | $73,800,361 | +1% | 0.8% |
| 2. | Fisher Asset Management Ken Fisher | 734,543 | $46,680,207 | +4% | 0.02% |
| 3. | 48,570,000 | $46,598,262 | 2.3% | ||
| 4. | SG Capital Management Ken Grossman And Glen Schneider | 719,432 | $45,719,904 | -19% | 4.21% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 648,645 | $41,221,390 | +132% | 0.05% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $80.93 | 4,000 | $323,720.00 | 12,048 | 2020-08-11 | Filing | |
| $35.00 | 60,000 | $2,099,754.00 | 105,867 | 2016-08-04 | Filing | |
| $32.73 | 412 | $13,482.70 | 31,522 | 2013-04-30 | Filing | |
| $32.73 | 615 | $20,125.88 | 17,279 | 2013-04-30 | Filing | |
| $32.73 | 245 | $8,017.63 | 16,751 | 2013-04-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $91.15 | 4,312 | $393,038.80 | 18,196 | 2024-07-26 | Filing | |
| $90.00 | 79 | $7,110.00 | 21,331 | 2024-07-12 | Filing | |
| $90.00 | 2,136 | $192,240.00 | 21,410 | 2024-07-11 | Filing | |
| $88.57 | 4,094 | $362,605.58 | 31,257 | 2024-05-29 | Filing | |
| $87.86 | 8,896 | $781,602.56 | 35,351 | 2024-05-29 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 39,857 | $2,973,731 | 0.04% | |
| 2. | 7,623 | $568,752 | 0.07% | |
| 3. | 4,223 | $315,078 | 0.16% | |
| 4. | 3,138 | $234,126 | 0.07% | |
| 5. | 669 | $49,914 | 0% |
News See All
11 Best Russell 2000 Stocks to Buy According to Wall Street Analysts
Since President Trump announced new tariffs, the U.S. stock market has been steadily declining. The Wall Street Journal has estimated the loss to be around $6.6 trillion.
10 Pro-Life Companies to Invest In Now
Investing isn’t just about numbers—it’s also about values.
Haemonetics Corporation (NYSE:HAE) Q3 2025 Earnings Call Transcript
Operator: Good day, and welcome to the Haemonetics Third Quarter Fiscal Year 2025 Conference Call and Webcast. At this time, all participants are in a listen-only-mod.
Haemonetics Corporation (NYSE:HAE) Q2 2025 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Second Quarter 2025 Haemonetics Corporation Earnings Conference Call. At this time, all participants are in a listen-only mode.
Haemonetics Corporation (NYSE:HAE) Q1 2025 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to Haemonetics Corporation’s First Quarter Fiscal Year 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Haemonetics Corporation (NYSE:HAE) Q4 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Q4 2024 Haemonetics Corporation Earnings Conference Call. At this time, all participants are in a listen-only mode.
25 Most Valuable Medical Device Companies in the US
In this article, we will be taking a look at the 25 most valuable medical device companies in the US.
Haemonetics Corporation (NYSE:HAE) Q3 2024 Earnings Call Transcript
Haemonetics Corporation beats earnings expectations. Reported EPS is $1.04, expectations were $0.97.
Haemonetics Corporation (NYSE:HAE) Q2 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by, and welcome to the Second Quarter 2024 Haemonetics Corporation Earnings Conference Call. At this time, all participants are in a listen-only mode.
Billionaire Hedge Funds
